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INTRODUCTION
Desmoid tumors account for approximately 0.3% of all
solid tumors.
1 The chest wall represents 8-10% of all cases,
and surgery is the primary treatment modality for sporadic
resectable desmoid tumors.
2,3 Currently, the term ‘‘sarcoma
with low-grade malignancy’’ is preferred, due the tendency
of these tumors toward local invasion and frequent
recurrence, even after complete surgical resection.
4
There have been few specific studies on chest wall
tumors. However, its treatment may involve peculiarities,
such as a difficulty in obtaining free surgical margins
(particularly in the axillary region and in the cervicothoracic
transition). We present our experience over the past eleven
years in an attempt to identify the risk factors for recurrence
in patients with desmoid tumors located exclusively on the
chest wall.
PATIENTS AND METHODS
This is a retrospective review of all patients who under-
went chest wall resections to treat desmoid tumors in the
Division of Thoracic Surgery, University of Sa ˜o Paulo
Medical School, Brazil, between 1998 and 2009.
The preoperative evaluation included an assessment of
the local tumor extension in all of the patients. A chest
computed tomography (CT) scan was used to assess the
tumor size and its extension into the muscle, ribs, sternum,
and vessels. The patients were directly referred to surgery,
and, following the establishment of an intra-operative
histopathological diagnosis of desmoid tumor, radical
resection was attempted and 4 cm of healthy tissue was
removed from around the tumor margin. Pre-operative
biopsies were performed only if the proposed procedure
involved a high morbidity (tumors located in the axilla,
sternum and cervicothoracic transition) or if the procedure
required complex reconstruction, defined by the impossi-
bility of primary closure.
Full-thickness resection was defined as a procedure that
involved bone resection. A polypropylene mesh was used in
the cases in which three or more consecutive ribs were
resected, and the plastic surgery team used muscle flaps
when required. All resected tumors were examined for
histology and margins.
Neither tamoxifen nor any other adjuvant treatment was
prescribed. The postoperative follow-up consisted of a
physical examination and CT scan every 6 months for two
years and, later, annual physical examinations and CT scans
for three years. However, patients with positive margins
underwent physical examinations and CT scans every three
months for two years and, later, physical examinations
every six months and CT scans every year for ten years.
The analyzed records included the patients’ age, sex,
symptoms, procedure, surgical margins, reconstruction
techniques, operative morbidity and mortality, recurrence
and global mortality. The operative deaths included the
patients who died within the first 30 days following surgery
or during the same hospitalization. The endpoints included
an assessment of the cumulative proportion risk factors for
recurrence. Follow-up information was obtained from all of
the patients through clinic office visits or telephone inter-
views with either the patient, a relative, or their primary
physician.
The assessed factors for a possible association with
recurrence were the patients’ age, sex, margin status,
resection thickness and previous biopsy performance. A
univariate statistical analysis was conducted using Fisher’s
test with a significance level of 0.05. The odds of recurrence
over time (depending on the tumor margins and resection
thickness) were demonstrated using a survival curve. A
multivariate analysis was not conducted due to the small
number of patients.
RESULTS
The study included 19 patients (10 men and 9 women).
The mean age at the time of resection was 36.9 years
(standard deviation, 13.46 years). Follow-ups were com-
pleted for all of the patients, with a mean of 36.6 months (12
to 129 months). Tumors were located in the anterior chest
wall (10), cervicothoracic transition (6), axillae (2) and
thoracic spine (1). A preoperative diagnostic biopsy was
performed in 13 patients (68%). In all of these cases, an
incisional biopsy was performed.
A full-thickness resection was performed in 10 (52.6%) of
the patients. The mean number of ribs resected was 2.4 ribs
(1 to 4 ribs), with a clavicle resection and scapulothoracic
disarticulation in one patient each. The mean tumor size
(largest diameter) was 13.94 cm (5 to 29 cm) (Figure 1).
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705Reconstruction techniques included the use of Marlex mesh
in 7 (36.8%) of the patients and muscle flaps in 4 (21%) of the
patients, which were isolated from the pectoralis major in 3
cases and the latissimus dorsi and pectoralis major in 1 patient.
Complications occurred in 5 (26%) of the patients: 4 (21%)
had wound infections and 1 (5.2%) had an incisional hernia,
which was treated surgically with a polypropylene mesh.
There were no perioperative deaths. The mean hospitaliza-
tion duration was 8 days (1 to 36 days). All of the patients
who were followed in this study are still alive, with the
exception of one patient who died due to cardiovascular
disease.
Tumors recurred in 4 of the patients (21%), and the mean
disease-free interval was 41 months (8 to 101 months with a
standard deviation of 43.09 months). All recurrences were
diagnosed by a physical examination. Positive surgical
margins were exclusively microscopic and affected 9 of the
19 patients (47%). These patients had tumors in the cervi-
cothoracic transition (6/9), in the axillae with axillary vessel
involvement (2/9) and in the thoracic spine (1/9). Of the
patients with negative margins, 80% (8/10) had no recurrence;
however, of the patients with positive margins, 77.8% (7/9)
also had no recurrence. Recurrence was present in 2 (22.2%) of
these patients who then underwent either a full- or partial-
thickness chest wall resection. All of the patients with
recurrence were given resections again. One of the four
patients died due to an acute myocardial infarction thirteen
months after the second operation, with no signs of recurrence.
The other three patients are alive, after a mean recurrence-free
interval of 36.6 months, with no signs of recurrence. Table 1
summarizes various characteristics of the patients.
The full results of the statistical analysis are indicated in
Table 2. Male sex was a risk factor (p=0.05). None of the
other variables were found to be recurrence-associated
factors (Table 2). The overall cumulative proportion and the
cumulative proportion of recurrence depending on the
margin status and resection thickness were calculated using
a Kaplan-Meier curve (Figures 2, 3, and 4). Positive margins
and the resection thickness were not significant risk factors
for a later recurrence, both with an odds ratio (OR) of 1.1428
(95% Confidence Interval [CI] =0.3392 to 28.0204).
DISCUSSION
Achieving negative margins should be the goal; however,
given the propensity of the tumor to invade vital structures,
obtaining negative margins for desmoid tumors involving
some chest regions often represents a challenge for the
surgeon.
5 Moreover, the prognostic significance of micro-
scopically positive margins remains controversial. In our
series, microscopically positive margins were present in 9
patients (47%), but only 2 (22%) of these patients experi-
enced recurrence. The other 7 patients had a mean disease-
free survival time of 31.2 months (12 to 78 months). The
patients with positive margins had large tumors (mean,
12 cm) in regions where it is difficult to obtain margins, such
as the cervicothoracic transition, the axillae (with axillary
vessel involvement) and the thoracic spine. Thus, we believe
that the incidence of positive margins was high.
Abbas et al. reported 53 cases of desmoid tumors of the
chest wall that were surgically treated and concluded that
microscopically positive margins are a risk factor for
recurrence (p,0.0001).
5 However, Lev et al. described the
outcomes of 146 patients who underwent operations for
desmoid tumors at the M.D. Anderson Cancer Center and
concluded that patients with microscopically positive or
negative margins had no differences in their long-term
recurrence rates (19% vs. 16%).
6
This topic is particularly important when dealing with
tumors that require disfiguring or extensive operations to
obtain histologically negative margins. In these particular
situations, the focus should perhaps be on the preservation
of organ function and the patients’ quality of life rather than
on striving for microscopically negative margins (at least in
the first resection). Moreover, in contrast to most malignant
tumors, the local recurrence of a desmoid tumor does not
seem to portend an increased likelihood of uncontrolled
future tumor growth.
7
Although conducted with few patients, this study
assesses one of the largest series of patients with desmoid
tumors located exclusively on the chest wall over a more
recent retrospective period (11 years). This study suggests
that microscopically positive margins alone may not
predict recurrence, without the bias of radiotherapy.
Male sex was a risk factor for recurrence, but similar
Figure 1 - Patient presenting a large desmoid tumor on the
posterior thoracic wall.
Table 1 - Descriptive characteristics of the patients.
Total patients 19 (100%)
Younger than 40 years 12/19 (63.1%)
Male 10/19 (52.6%)
Positive margins 9/19 (47.3%)
Full-thickness resection 10/19 (52.6%)
Previous biopsy 13/19 (68.4%)
Recurrence 4/19 (21%)
Table 2 - Variables tested for the evaluation of
recurrence.
Variable P value
95% confidence
interval
younger than 40 years 0.52 -24.95 to 46.38
Male 0.05 9.63 to 70.36
Positive margins 0.66 -34.55 to 38.99
Full-thickness resection 0.24 -59.31 to 12.64
Previous biopsy 0.18 5.68 to 55.86
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706results were not observed in the literature. One hypothesis
is that male patients, who have less estrogen than do
female patients, do not benefit from hormonal depriva-
tion. However, in our sample, hormonal deprivation was
not used. This result needs to bec o n f i r m e d ,b u ti tm a yb e
important for thoracic surgeons in the cases of large
tumors in areas where negative surgical margins are
difficult to achieve.
We conclude that male patients seem to have an increased
risk of recurrence and that the status of the margins and
other variables should be studied further. However, in the
cases where the first resection results in substantial
functional impairment in the form of a scapulothoracic
disarticulation or a significant increase in morbidity or
mortality, a resection with negative macroscopic margins
should not be a priority in selected cases.
Figure 2 - Cumulative proportion of recurrence events during follow-up (months).
Figure 3 - Cumulative proportion of recurrence events during follow-up (months).
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